Pharmaceutical Development and Bioavailability Analysis
A special issue of Processes (ISSN 2227-9717). This special issue belongs to the section "Pharmaceutical Processes".
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 107763
Special Issue Editors
Interests: prebiotics; probiotics; microbiota; microbiology control; infectious contaminants; food safety
Special Issues, Collections and Topics in MDPI journals
Interests: nutritional evaluation; nutritional biomarkers; practical nutrition; metabolic disease; diabetes
Special Issues, Collections and Topics in MDPI journals
Interests: drug development and analysis; pharmacokinetics; drug–drug interactions; experimental pharmacology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear colleagues,
The frontiers of pharmaceutical development have been broadly extended over the past few years, with a significant impact on the research, design, and manufacture of both novel synthetized substances and classic molecules that need an updating of their formulation or their bioavailability and use. In the century of nanoscale, the scientific and clinical approaches of pharmaceuticals are challenging and, in many cases, the necessity of emphasizing practical solutions and applications to theoretical and research-based problems occurs.
Nowadays, pharmaceutical development faces a large host of issues deriving from the particularities of each pharmacological active principle, from botanicals to biologics and biosimilars. In many cases, these molecules or the already formulated drugs create controversies regarding the bioavailability, interactions, novel potential mechanisms of action with consequences on their efficacy and risks.
Therefore, in this Special Issue titled “Pharmaceutical Development and Bioavailability Analysis”, we encourage researchers to present the most recent studies regarding various developments in the pharmaceutical field, with a strong focus on the drugs’ bioavailability and potential effects on the formulation, delivery systems, pharmacokinetics, interactions, and preclinical and clinical significance. The manuscripts may include research articles and reviews in order to advance the pharmaceutical development.
Prof. Dr. Andreea Letitia ArseneDr. Denisa Udeanu
Dr. Bruno Velescu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Processes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Preformulation and pharmaceutical formulation studies
- Bioavailability studies
- Drug–drug interactions
- Design of dosage forms
- Drug delivery systems research and quality improvement
- Medicinal chemistry
- Structure–property correlations
- Binding affinity
- Radiopharmaceuticals
- Animal experimentation and clinical trials
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.